Oncology nurses play a key role guiding patients about AI breast cancer risk assessment tools, dynamic re-testing, and ...

Michelle Mollica, PhD, MPH, RN, OCN, of the National Cancer Institute, discusses how childhood cancer survivors may face different challenges than adult or geriatric patients. Childhood cancer ...

The approval covers IV and subcutaneous pembrolizumab and raises the TMB-H threshold from 10 to 13 mutations/megabase.

European survey reveals how oncology nurses manage complex multiple myeloma care amid time and resource constraints. Keeping pace with innovation requires nurses to balance a growing volume of ...

Eppie Bass, APRN, explains how nurses can counsel patients on flu-like symptoms vs warning signs with nogapendekin alfa inbakicept-pmln and BCG.

Erika Hamilton, MD, breaks down liver monitoring, diarrhea, creatinine shifts, and oral adherence with maintenance tucatinib ...

Among patients with bacillus Calmette-Guérin (BCG)–unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) who achieved a complete response (CR) with nogapendekin alfa ...

The FDA granted accelerated approval to dostarlimab (Jemperli) on October 19, 2026, for adults with stage II/III locally ...

Alongside urinary symptoms, the regimen can cause systemic effects such as chills, fever, and musculoskeletal pain. Eppie ...

Throughout treatment and survivorship, patients may experience fatigue, anxiety, changes in physical functioning, loss of confidence, isolation, and difficulty adjusting. As healthcare professionals ...

NP Theresa Stukus and NP Nelli Zafman conclude the discussion by reflecting on the resources, practice changes, and ...

Breast cancer survivors are increasingly asking their care teams about glucagon-like peptide-1 (GLP-1) receptor agonists, and two nurses at Winship Cancer Institute of Emory University say the most ...